is fda stopping semaglutide Warns on Certain Forms of Compounded Semaglutide shortage ends as FDA

Aguayo-Mazzucato, C

The starting dose for the tablet is 1.5 mg once daily, increasing to a maximum 25 mg dose

Diarrhea is most common when starting Ozempic or increasing the dose, and it usually improves within a few weeks

Appetite suppression requires higher receptor occupancy than these doses provide

It's important to note that while Wegovy and Zepbound are FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, similar medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved only for type 2 diabetes management

Many patients remain on it long-term and adjust doses as needed